These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9505083)

  • 21. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of glucose control, lipoproteins, and haemostasis function on brachial endothelial reactivity and carotid intima-media area, stiffness and diameter in Type 1 diabetes mellitus patients.
    Johansson J; Reichard P; Jensen-Urstad K; Rosfors S; Jensen-Urstad M
    Eur J Clin Invest; 2003 Jun; 33(6):472-9. PubMed ID: 12795643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.
    Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T; Fukuhara S
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):205-15. PubMed ID: 15247977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agarose gel electrophoresis with nitroblue tetrazolium coloration for determination of glycated lipoproteins in serum from diabetics.
    Kobayashi K; Ogasahara N; Sakoguchi T; Kimura M; Taniuchi K; Matsuoka A
    Clin Chem; 1990 Jan; 36(1):65-9. PubMed ID: 1688747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasoprotective and vasoaggressive characteristics of serum lipoproteins].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Dec; 120(50):1671-2. PubMed ID: 214704
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus.
    Winocour PH; Durrington PN; Ishola M; Anderson DC; Cohen H
    Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1648-51. PubMed ID: 3113568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structure and metabolism of plasma lipoproteins: effect of atherosclerosis].
    Fellin R
    G Ital Cardiol; 1976; 6(5):961-7. PubMed ID: 188709
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
    Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
    Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.
    Tolonen N; Forsblom C; Mäkinen VP; Harjutsalo V; Gordin D; Feodoroff M; Sandholm N; Thorn LM; Wadén J; Taskinen MR; Groop PH;
    Diabetes Care; 2014 Aug; 37(8):2374-82. PubMed ID: 24879842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum C4 concentrations and microangiopathy in type I and type II diabetes.
    Cooper ME; Duff R; Buchanan R; McPherson J; Jerums G
    Br Med J (Clin Res Ed); 1986 Mar; 292(6523):801. PubMed ID: 3082449
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma lipids and lipoproteins in diabetes: lessons from population-based studies.
    Laakso M; Pyörälä K
    J Diabet Complications; 1990; 4(2):39-41. PubMed ID: 2145294
    [No Abstract]   [Full Text] [Related]  

  • 36. From an excess of fat, diabetics die.
    Steiner G
    JAMA; 1989 Jul; 262(3):398-9. PubMed ID: 2491411
    [No Abstract]   [Full Text] [Related]  

  • 37. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes?
    Lyons TJ
    Diabet Med; 1991 Jun; 8(5):411-9. PubMed ID: 1830524
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
    Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR;
    Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A grading index of serum lipid abnormalities.
    Gubner RS
    Am J Cardiol; 1992 Dec; 70(18):1514. PubMed ID: 1442634
    [No Abstract]   [Full Text] [Related]  

  • 40. High density lipoproteins in diabetes.
    Nikkilä EA
    Diabetes; 1981; 30(Suppl 2):82-7. PubMed ID: 7028542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.